NCT05056155View on ClinicalTrials.gov

Systane Complete Multi-symptom Relief

NACompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

November 9, 2021

Primary Completion Date

March 25, 2022

Study Completion Date

March 25, 2022

Conditions
Dry Eye Disease
Interventions
OTHER

Systane Complete

Propylene glycol 0.6% eye drops for replenishing deficiencies in both the lipid and aqueous layers of the tear film

Trial Locations (4)

43023

Alcon Investigator 8046, Granville

43065

Alcon Investigator 6313, Powell

64111

Alcon Investigator 1455, Kansas City

78731

Alcon Investigator 8175, Austin

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY